Replacing lab rats? Bay Area tech fund backs Emulate's $36M round to commercialize 'organ chip' tech
After inking a slew of big pharma partnerships earlier this year, Emulate is stacking away $36 million in new capital to commercialize a drug-testing tech it hopes will one day replace the lab rat.
The round was led by a Bay Area tech investor group — Founders Fund — whose partners founded and funded companies like PayPal, Facebook, and SpaceX. While Emulate may not grow to those great heights, the company’s tech is pretty interesting to the drug dev crowd.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.